Fig. 3From: Enhancing dendritic cell immunotherapy for melanoma using a simple mathematical modelSimulation of immunotherapy for different amounts of DCs per dose. Interval injection every 168 hours during three weeks and applying 103 DCs per dose (Table 2, Protocol 3), a 19.92 % of decrease was obtained. Tumor population (thick line) and amount of DCs injected (dotted line) are shownBack to article page